Health Condition 1: F431- Post-traumatic stress disorder (PTSD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals with a primary diagnosis of PTSD (according to DSM-5 criteria) as assessed by Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) and those who obtain a score of 33 and above on Post Traumatic Stress Disorder Checklist (PCL-5) or Individuals with a primary diagnosis of CPTSD (according to ICD 11 criteria) Individuals having experienced the worst traumatic event (defined according to the DSM-5) before the age of 16 and agree that this trauma will be the focus of treatment. Individuals belonging to the age group of 18-60 years Individuals who have undergone psychological interventions for PTSD but continue to fulfill the criteria for the diagnosis of PTSD (Score of 33 and above on PCL-5) Individuals who can read and write English.
Exclusion criteria
Exclusion criteria: Individuals with schizophrenia, bipolar disorder with current episode mania/ severe depression, current substance use/substance dependence/harmful use not in remission for at least 3 months except nicotine use Individuals with an organic brain disorder, neurodevelopmental disorders, or intelligence below the average category Individuals with severe symptoms of axis I disorders that might interfere with their engagement in therapy Individuals with acute suicidal risk or self-harm Individuals with ongoing trauma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PTSD Symptom severity as assessed by PCL-5Timepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase. | — |
Secondary
| Measure | Time frame |
|---|---|
| AngerTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase.;AnxietyTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase.;DepressionTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase.;Emotional regulationTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase.;GuiltTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase.;PTSD related cognitionsTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase.;ShameTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase.;Well-beingTimepoint: 5 timepoints- Before baseline, After Baseline, before treatment, after treatment, at follow up which is 3 months after the treatment phase. | — |
Countries
India
Contacts
National Institute of Mental Health and Neurosciences